C-arm developer OEC Medical Systems of Salt Lake City reported last month that the Indiana Supreme Court has denied the company its petition for appeal of a suit brought by a terminated distributor in 1988. The final judgment is $4.9 million, including
C-arm developer OEC Medical Systems of Salt Lake City reported last month that the Indiana Supreme Court has denied the company its petition for appeal of a suit brought by a terminated distributor in 1988. The final judgment is $4.9 million, including interest, and the court's decision ends the litigation. Since OEC established a reserve in 1992 to cover the judgment, its operating costs will not be affected, according to the company. OEC executives declined to comment on the basis of the suit.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.